Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q4 CY2025, but sales fell by 29.8% year on year to $678 million. Its non-GAAP loss of $2.11 per share was 20.2% ...
Proteins need to interact in a complex manner for a so-called 'messenger RNA' (mRNA) to be created in human cells from a precursor molecule. mRNA provides a blueprint for proteins; the first vaccines ...
Scientists have discovered the internal shape of tiny drug-delivery particles - called lipid nanoparticles - has a big impact on how well our cells absorb them, paving the way to more efficient ...
Angie Hilliker has received funding from the National Institutes of Health. While using mRNA as medicine is new, mRNA has been inside you for your entire life. The cells in your body create mRNAs that ...
In the wake of its breakout COVID-19 success with Pfizer, BioNTech’s globetrotting mRNA ambitions are taking shape. The company’s latest move? A strategic partnership in the Land Down Under. Friday, ...
Deborah Fuller receives funding from the National Institutes of Health. She is co-founder and a scientific advisor for two biotech companies developing nucleic acid vaccine technologies that are not ...
BANGKOK - An mRNA booster is a follow-up vaccine dose that reminds the immune system what to fight. Think of it like a quick refresher before a big exam.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results